• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肿瘤性骨软化症相关的椎体病变的临床特征和手术结果:16 例患者报告及文献复习。

Clinical characteristics and surgical outcomes of vertebral lesions associated with tumor-induced osteomalacia: report of 16 patients and review of the literature.

机构信息

Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.

Department of Orthopedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

出版信息

Osteoporos Int. 2024 Nov;35(11):1951-1962. doi: 10.1007/s00198-024-07178-2. Epub 2024 Aug 2.

DOI:10.1007/s00198-024-07178-2
PMID:39093437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11499524/
Abstract

UNLABELLED

Vertebral tumors in patients with tumor-induced osteomalacia (TIO) have a low diagnostic rate and poor postoperative outcomes. The application of  Ga-DOTATATE-PET/CT significantly increased the detection rate. Compared with tumor curettage, segmental resection was recommended as the preferred surgical type due to its high recovery rate.

PURPOSE

Tumor-induced osteomalacia (TIO) is an acquired hypophosphatemic osteomalacia, and surgery is the first-line therapy. Most TIO tumors are found in the bones of the appendicular skeleton, cranium, and paranasal sinuses but rarely in the vertebrae. Tumor curettage and segmental resection are the two main surgical options for vertebral TIO patients. However, research on the clinical characteristics and surgical prognosis of vertebral TIO patients is rare. In the present study, for the first time, we investigated the clinical characteristics of 16 vertebral TIO patients and compared the surgical outcomes of patients who underwent surgery via two different surgical methods.

METHODS

This was a retrospective cohort study. In this study, we included 16 adult TIO patients with lesions in vertebrae from Peking Union Medical College Hospital (PUMCH), all of whom underwent surgery. Baseline laboratory data were collected through medical records review. Technetium-99 m octreotide scintigraphy (Tc-OCT) and gallium-DOTA-TATE-positron emission tomography/computed tomography ( Ga-DOTATATE-PET/CT) were conducted at the Department of Nuclear Medicine of PUMCH. The tumor histopathology was confirmed by a senior pathologist at our center.

RESULTS

Vertebral TIO patients had lower serum phosphorus and TmP/GFR and higher serum alkaline phosphatase (ALP), serum parathyroid hormone (PTH), and serum C-terminal cross-linked telopeptide of type I collagen (β-CTX) levels than the normal range. The sensitivity of  Ga‒DOTATATE PET/CT was 100%, significantly greater than that of Tc-OCT (40%). After comparing the outcomes between the two surgical methods, we found that the recovery rate after segmental resection (62.5%) was greater than that after tumor curettage (12.5%). In the thoracic and sacral vertebrae, segmental resection surgery had a good prognosis.

CONCLUSION

Ga-DOTATATE PET/CT could serve as the first diagnostic tool in patients with vertebral TIO, and segmental resection could be used as the preferred surgery. This study would raise awareness of the clinical features and management of these rare vertebral TIO patients.

摘要

目的

肿瘤诱导性骨软化症(TIO)是一种获得性低磷性骨软化症,手术是一线治疗方法。大多数 TIO 肿瘤发生在四肢骨骼、颅骨和副鼻窦,但很少发生在椎骨。肿瘤刮除术和节段切除术是治疗椎骨 TIO 患者的两种主要手术选择。然而,关于椎骨 TIO 患者的临床特征和手术预后的研究很少。在本研究中,我们首次调查了 16 例椎骨 TIO 患者的临床特征,并比较了两种不同手术方法治疗的患者的手术结果。

方法

这是一项回顾性队列研究。在这项研究中,我们纳入了 16 例来自北京协和医院(PUMCH)的椎骨 TIO 成年患者,所有患者均接受了手术。通过病历回顾收集基线实验室数据。核医学科进行锝-99m 奥曲肽闪烁扫描(Tc-OCT)和镓-DOTA-TATE-正电子发射断层扫描/计算机断层扫描(Ga-DOTATATE-PET/CT)。肿瘤组织病理学由我们中心的一位资深病理学家证实。

结果

椎骨 TIO 患者的血清磷和 TmP/GFR 较低,而血清碱性磷酸酶(ALP)、血清甲状旁腺激素(PTH)和血清 I 型胶原 C 端交联肽(β-CTX)水平较高。Ga-DOTATATE-PET/CT 的灵敏度为 100%,明显高于 Tc-OCT(40%)。比较两种手术方法的结果后,我们发现节段切除术(62.5%)的恢复率大于肿瘤刮除术(12.5%)。在胸腰椎,节段切除术有良好的预后。

结论

Ga-DOTATATE-PET/CT 可作为椎骨 TIO 患者的首选诊断工具,节段切除术可作为首选手术方法。本研究将提高对这些罕见椎骨 TIO 患者的临床特征和治疗的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fff/11499524/fbe402eb48ef/198_2024_7178_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fff/11499524/51f1ee31a382/198_2024_7178_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fff/11499524/a9a50407d1e4/198_2024_7178_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fff/11499524/fbe402eb48ef/198_2024_7178_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fff/11499524/51f1ee31a382/198_2024_7178_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fff/11499524/a9a50407d1e4/198_2024_7178_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fff/11499524/fbe402eb48ef/198_2024_7178_Fig3_HTML.jpg

相似文献

1
Clinical characteristics and surgical outcomes of vertebral lesions associated with tumor-induced osteomalacia: report of 16 patients and review of the literature.与肿瘤性骨软化症相关的椎体病变的临床特征和手术结果:16 例患者报告及文献复习。
Osteoporos Int. 2024 Nov;35(11):1951-1962. doi: 10.1007/s00198-024-07178-2. Epub 2024 Aug 2.
2
Reports of 17 Chinese patients with tumor-induced osteomalacia.17例肿瘤诱导性骨软化症中国患者的报告。
J Bone Miner Metab. 2017 May;35(3):298-307. doi: 10.1007/s00774-016-0756-9. Epub 2016 Apr 16.
3
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.
4
Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia.18F-AlF-NOTA-Octreotide PET/CT 在肿瘤相关性骨软化症定位中的应用。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4202-e4209. doi: 10.1210/clinem/dgab258.
5
68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.68Ga DOTA-TATE PET/CT能够在肿瘤诱导的骨软化症患者中定位肿瘤,而这些患者的111In-奥曲肽SPECT/CT检查结果为阴性。
Bone. 2014 Jul;64:222-7. doi: 10.1016/j.bone.2014.04.016. Epub 2014 Apr 24.
6
Diagnostic performance of Ga-DOTATOC PET/CT in tumor-induced osteomalacia.镓[68Ga]DOTATOC PET/CT 在肿瘤性骨软化症中的诊断性能。
Ann Nucl Med. 2021 Mar;35(3):397-405. doi: 10.1007/s12149-021-01575-x. Epub 2021 Feb 13.
7
F-AlF-NOTA-octreotide PET/CT in the localization of tumor-induced osteomalacia: case series and literature review.F-AlF-NOTA-奥曲肽 PET/CT 在肿瘤相关性骨软化症定位中的应用:病例系列和文献复习。
Front Endocrinol (Lausanne). 2024 Jun 3;15:1400751. doi: 10.3389/fendo.2024.1400751. eCollection 2024.
8
Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.镓-多柔比星用于肿瘤性骨软化症的肿瘤定位
J Clin Endocrinol Metab. 2016 Oct;101(10):3575-3581. doi: 10.1210/jc.2016-2052. Epub 2016 Aug 17.
9
Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.与磷尿性间叶肿瘤相关的肿瘤性骨软化症的治疗及预后:12例患者的回顾性分析
BMC Musculoskelet Disord. 2017 Sep 21;18(1):403. doi: 10.1186/s12891-017-1756-1.
10
Tumor-induced osteomalacia: experience from a South American academic center.肿瘤相关性骨软化症:来自一家南美学术中心的经验。
Osteoporos Int. 2017 Jul;28(7):2187-2193. doi: 10.1007/s00198-017-4007-2. Epub 2017 Mar 25.

本文引用的文献

1
Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.肿瘤相关性骨软化症的识别、诊断和管理全球指南。
J Intern Med. 2023 Mar;293(3):309-328. doi: 10.1111/joim.13593. Epub 2022 Dec 13.
2
Tumor-induced osteomalacia treated with T12 tumor resection.经T12肿瘤切除治疗的肿瘤诱导性骨软化症
Endocrinol Diabetes Metab Case Rep. 2022 Dec 1;2022. doi: 10.1530/EDM-22-0344.
3
Tumor-induced Osteomalacia: A Systematic Review and Individual Patient's Data Analysis.肿瘤相关性骨软化症:系统评价和个体患者数据分析。
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3428-e3436. doi: 10.1210/clinem/dgac253.
4
Tumor induced osteomalacia - A long way toward correct diagnosis and management.肿瘤诱导性骨软化症——迈向正确诊断与治疗的漫长之路。
Bone Rep. 2022 Mar 8;16:101180. doi: 10.1016/j.bonr.2022.101180. eCollection 2022 Jun.
5
Early Discrimination Between Tumor-Induced Rickets/Osteomalacia and X-Linked Hypophosphatemia in Chinese Children and Adolescents: A Retrospective Case-Control Study.中文儿童和青少年肿瘤相关性佝偻病/骨软化症与 X 连锁低磷血症的早期鉴别:一项回顾性病例对照研究。
J Bone Miner Res. 2021 Sep;36(9):1739-1748. doi: 10.1002/jbmr.4331. Epub 2021 May 19.
6
Consensus on clinical management of tumor-induced osteomalacia.肿瘤诱导性骨软化症临床管理共识
Chin Med J (Engl). 2021 Apr 1;134(11):1264-1266. doi: 10.1097/CM9.0000000000001448.
7
Clinical Characteristics and Surgical Outcomes of Sinonasal Lesions Associated With Tumor-Induced Osteomalacia.与肿瘤性骨软化症相关的鼻窦病变的临床特征和手术结果。
Otolaryngol Head Neck Surg. 2021 Jul;165(1):223-231. doi: 10.1177/0194599820975432. Epub 2020 Dec 8.
8
Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.复发性脊柱磷尿性间叶肿瘤所致骨软化症的外科治疗:1例报告
Medicine (Baltimore). 2020 Jan;99(4):e18603. doi: 10.1097/MD.0000000000018603.
9
Tumor-induced Osteomalacia due to a Phosphaturic Mesenchymal Tumor in the Cervical Spine: A Case Report and Literature Review.肿瘤性骨软化症由颈椎中的磷酸盐尿性间叶肿瘤引起:病例报告及文献复习。
Neurol India. 2019 Sep-Oct;67(5):1334-1340. doi: 10.4103/0028-3886.271274.
10
Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.非缓解性和复发性肿瘤诱导的骨软化症:一项回顾性研究。
J Bone Miner Res. 2020 Mar;35(3):469-477. doi: 10.1002/jbmr.3903. Epub 2019 Nov 15.